Cost of Revenue in USD of Niagen Bioscience, Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Niagen Bioscience, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q3 2025.
  • Niagen Bioscience, Inc. Cost of Revenue for the quarter ending September 30, 2025 was $12.1M, a 29.1% increase year-over-year.
  • Niagen Bioscience, Inc. Cost of Revenue for the twelve months ending September 30, 2025 was $45M, a 27.4% increase year-over-year.
  • Niagen Bioscience, Inc. annual Cost of Revenue for 2024 was $38M, a 15.9% increase from 2023.
  • Niagen Bioscience, Inc. annual Cost of Revenue for 2023 was $32.8M, a 12.1% increase from 2022.
  • Niagen Bioscience, Inc. annual Cost of Revenue for 2022 was $29.3M, a 12.7% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)

Niagen Bioscience, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $45M $12.1M +$2.72M +29.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $42.3M $10.9M +$1.85M +20.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $40.5M $11.2M +$2.45M +28.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $38M $10.9M +$2.67M +32.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-04
Q3 2024 $35.3M $9.34M +$1.81M +24.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $33.5M $9.05M +$1.08M +13.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $32.4M $8.7M -$341K -3.77% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $32.8M $8.26M -$721K -8.03% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-04
Q3 2023 $33.5M $7.53M +$670K +9.77% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $32.8M $7.97M +$1.28M +19.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $31.6M $9.04M +$2.31M +34.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $29.3M $8.98M +$2.09M +30.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $27.2M $6.86M +$126K +1.87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $27M $6.69M -$199K -2.89% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $27.2M $6.73M +$1.28M +23.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $26M $6.89M +$867K +14.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $25.1M $6.73M +$1M +17.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $24.1M $6.89M +$690K +11.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $23.4M $5.45M -$585K -9.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $24M $6.02M +$400K +7.11% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $23.6M $5.73M +$422K +7.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $23.2M $6.2M +$1.35M +27.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $21.8M $6.03M +$1.29M +27.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $20.5M $5.62M +$1.27M +29.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $19.3M $5.3M +$1.55M +41.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $17.7M $4.85M +$890K +22.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $16.8M $4.75M +$1.32M +38.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 $15.5M $4.36M +$660K +17.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $14.8M $3.76M +$590K +18.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $14.3M $3.96M +$1.85M +87.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $12.4M $3.43M +$1.68M +96% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $10.7M $3.7M +$3.08M +499% Oct 1, 2017 Dec 30, 2017 10-K 2019-03-07
Q3 2017 $7.65M $3.17M +$1.09M +52.8% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $6.55M $2.11M -$2.59M -55.1% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-09
Q1 2017 $9.14M $1.75M -$2.13M -54.9% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-10
Q4 2016 $11.3M $617K +$1.04M Oct 2, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $10.2M $2.07M -$1.73M -45.5% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-09
Q2 2016 $12M $4.7M +$1.07M +29.5% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-10
Q1 2016 $10.9M $3.88M +$547K +16.4% Jan 3, 2016 Apr 2, 2016 10-Q 2017-05-11
Q4 2015 $10.4M -$419K -$3.24M -115% Oct 4, 2015 Jan 2, 2016 10-K 2018-03-15
Q3 2015 $13.6M $3.81M +$1.19M +45.4% Jul 5, 2015 Oct 3, 2015 10-Q 2016-11-10
Q2 2015 $12.4M $3.63M +$1.17M +47.7% Apr 5, 2015 Jul 4, 2015 10-Q 2016-08-11
Q1 2015 $11.2M $3.33M +$1.24M +59.6% Jan 3, 2015 Apr 4, 2015 10-Q 2016-05-12
Q4 2014 $9.99M $2.82M +$1.17M +71% Sep 28, 2014 Jan 3, 2015 10-K 2017-03-16
Q3 2014 $8.82M $2.62M +$649K +33% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-12
Q2 2014 $8.17M $2.46M +$711K +40.7% Mar 30, 2014 Jun 28, 2014 10-Q 2015-08-13
Q1 2014 $7.46M $2.09M +$427K +25.7% Dec 29, 2013 Mar 29, 2014 10-Q 2015-05-14
Q4 2013 $7.03M $1.65M -$1.01M -37.9% Sep 29, 2013 Dec 28, 2013 10-K 2016-03-17
Q3 2013 $8.04M $1.97M -$410K -17.2% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-06
Q2 2013 $8.45M $1.75M -$160K -8.38% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-12
Q1 2013 $8.61M $1.66M -$727K -30.4% Dec 30, 2012 Mar 30, 2013 10-Q 2014-05-08
Q4 2012 $9.34M $2.66M +$1.26M +89.6% Sep 30, 2012 Dec 29, 2012 10-K 2014-03-27
Q3 2012 $8.08M $2.38M +$1.02M +74.7% Jul 1, 2012 Sep 29, 2012 10-Q 2013-11-21
Q2 2012 $7.06M $1.91M +$549K +40.4% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-12-05
Q1 2012 $6.51M $2.39M +$870K +57.3% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-12-05
Q4 2011 $5.64M $1.4M Oct 2, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 $1.36M +$301K +28.5% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-08
Q2 2011 $1.36M +$98.9K +7.86% Apr 3, 2011 Jul 2, 2011 10-Q/A 2012-08-10
Q1 2011 $1.52M Jan 3, 2011 Apr 2, 2011 10-Q 2012-05-10
Q3 2010 $1.06M Jul 3, 2010 Oct 2, 2010 10-Q 2011-11-10
Q2 2010 $1.26M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-11

Niagen Bioscience, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $38M +$5.22M +15.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $32.8M +$3.54M +12.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $29.3M +$3.29M +12.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $26M +$1.98M +8.24% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $24M +$3.46M +16.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $20.5M +$5.02M +32.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $15.5M +$4.78M +44.6% Dec 31, 2017 Dec 31, 2018 10-K 2020-03-10
2017 $10.7M -$550K -4.88% Jan 1, 2017 Dec 30, 2017 10-K 2019-03-07
2016 $11.3M +$924K +8.93% Jan 3, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $10.4M +$363K +3.63% Jan 4, 2015 Jan 2, 2016 10-K 2018-03-15
2014 $9.99M +$2.96M +42.1% Dec 29, 2013 Jan 3, 2015 10-K 2017-03-16
2013 $7.03M -$2.31M -24.7% Dec 30, 2012 Dec 28, 2013 10-K 2016-03-17
2012 $9.34M +$3.69M +65.5% Jan 1, 2012 Dec 29, 2012 10-K 2014-03-27
2011 $5.64M +$1.02M +22.1% Jan 2, 2011 Dec 31, 2011 10-K 2013-03-29
2010 $4.62M Jan 3, 2010 Jan 1, 2011 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.